192 related articles for article (PubMed ID: 32958629)
1. Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.
Lobb DC; Doviak H; Brower GL; Romito E; O'Neill JW; Smith S; Shuman JA; Freels PD; Zellars KN; Freeburg LA; Khakoo AY; Lee T; Spinale FG
J Pharmacol Exp Ther; 2020 Nov; 375(2):296-307. PubMed ID: 32958629
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
4. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
Zavadzkas JA; Stroud RE; Bouges S; Mukherjee R; Jones JR; Patel RK; McDermott PJ; Spinale FG
Circ Res; 2014 Apr; 114(9):1435-45. PubMed ID: 24637197
[TBL] [Abstract][Full Text] [Related]
5. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
Dixon JA; Gorman RC; Stroud RE; Mukherjee R; Meyer EC; Baker NL; Morita M; Hamamoto H; Ryan LP; Gorman JH; Spinale FG
Circulation; 2011 Sep; 124(11 Suppl):S35-45. PubMed ID: 21911817
[TBL] [Abstract][Full Text] [Related]
6. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
7. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.
Eckhouse SR; Purcell BP; McGarvey JR; Lobb D; Logdon CB; Doviak H; O'Neill JW; Shuman JA; Novack CP; Zellars KN; Pettaway S; Black RA; Khakoo A; Lee T; Mukherjee R; Gorman JH; Gorman RC; Burdick JA; Spinale FG
Sci Transl Med; 2014 Feb; 6(223):223ra21. PubMed ID: 24523321
[TBL] [Abstract][Full Text] [Related]
8. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
[TBL] [Abstract][Full Text] [Related]
9. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
[TBL] [Abstract][Full Text] [Related]
10. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
11. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
12. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.
Dixon JA; Gorman RC; Stroud RE; Bouges S; Hirotsugu H; Gorman JH; Martens TP; Itescu S; Schuster MD; Plappert T; St John-Sutton MG; Spinale FG
Circulation; 2009 Sep; 120(11 Suppl):S220-9. PubMed ID: 19752372
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarct expansion and matrix metalloproteinase inhibition.
Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
[TBL] [Abstract][Full Text] [Related]
18. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
Spinale FG; Mukherjee R; Zavadzkas JA; Koval CN; Bouges S; Stroud RE; Dobrucki LW; Sinusas AJ
J Biol Chem; 2010 Sep; 285(39):30316-27. PubMed ID: 20643648
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.
Tian H; Huang ML; Liu KY; Jia ZB; Sun L; Jiang SL; Liu W; McDonald Kinkaid HY; Wu J; Li RK
Cell Transplant; 2012; 21(5):1039-53. PubMed ID: 21944319
[TBL] [Abstract][Full Text] [Related]
20. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.
Lindsey ML; Zamilpa R
Cardiovasc Ther; 2012 Feb; 30(1):31-41. PubMed ID: 20645986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
